Cancer Epidemiology

  • Epidemiology, Public Health, Prevention and Survivorship
Dr. Renée Turzanski Fortner

Dr. Renée Turzanski Fortner

Head of Division

The overarching goal of the Division’s research is to provide insights on the etiology of cancer, strategies for prevention and earlier detection, and predictors of survival, with the goal of reducing the morbidity and mortality associated with a cancer diagnosis.

Logo DKFZ

Our Research

On the basis of established, genetic and non-genetic risk factors, we build quantitative risk models for the identification of individuals who have an increased risk of developing cancer compared to others, and who may gain increased benefit from targeted prevention measures such as regular cancer screening.

A further focus is exploring new routes for prevention and early diagnosis of cancer, as well as quality control of introduced measures. Due to their population-related approach, statistical methods and their further development are of particularly high relevance in epidemiology.

A major part of our research takes place within the setting of large-scale prospective cohort studies, such as the European Prospective Investigation into Cancer and Nutrition (EPIC) and the Scandinavian Consortium of Maternity Cohorts. Besides these prospective studies in the general population, our division conducts studies within large cohorts of cancer patients.

FUTURE OUTLOOK
Studies within our various prospective cohorts are increasingly making use of modern, high-throughput “omics” technologies (metabolomics, genomics, epigenomics, next-generation sequencing) for the identification of risk factors and predictors for cancer and markers for early detection.
For future studies, our division has a central role in the development and set-up of the “NAKO” – a new, large-scale prospective cohort study in Germany.

Team

  • Employee image

    Dr. Renée Turzanski Fortner

    Head of Division

Our Team

NAKO Study Center Mannheim

  • Employee image

    Yuliya Ertel

  • Employee image

    Altan Adanali

  • Employee image

    Farah Alam

  • Employee image

    Mailin Anna Theresia Antl

  • Employee image

    Annika Baert

  • Employee image

    Özlem Bedir

  • Employee image

    Nimet Demir

  • Employee image

    Patrycja Hamryszak

  • Employee image

    Silke Kahmann

  • Employee image

    Torben Loßmann

  • Employee image

    Anna-Constanze Mast

  • Employee image

    Ute Metzger

  • Employee image

    Ute Muskatewitz

  • Employee image

    Colin Ofenloch

  • Employee image

    Louisa Sautner

  • Employee image

    Maria Antonia Scafiti

  • Employee image

    Rita Schanzenbach-Bauer

  • Employee image

    Christine Schestak

  • Employee image

    Leni Schwarzwälder

  • Employee image

    Jasmin Tabakhtory-Fard

  • Employee image

    Nicoleta-Sanda Veredas Caballero

  • Employee image

    Luisa Wagner

  • Employee image

    Gülsüm Yurtseven

Our Projects

A key focus of our research is the prevention and early detection of lung cancer. Through various national and international projects, we are investigating how lung cancer risks can be identified early, how to reach appropriate individuals for early detection programs, and how screening services can be implemented effectively and equitably.

Among other things, we focus on evaluating lung cancer screening using low-dose computed tomography (LDCT), participation in screening programs, social and regional disparities in uptake, as well as issues related to health literacy, risk communication, and smoking cessation. Our work is based on data from epidemiological studies, screening projects, and healthcare systems.

Our research aims to contribute to further developing the evidence for effective, target-group-appropriate, and equitable lung cancer screening and to support its translation into clinical practice.

LUSI

The German Lung Cancer Screening Intervention Study (LUSI) investigates the benefits of lung cancer screening using low-dose computed tomography (LDCT) in individuals at increased risk for lung cancer.

[Read more]

4-IN-THE-LUNG-RUN

4-IN-THE-LUNG-RUN (4ITLR) is a European research project aimed at further developing risk-based strategies for lung cancer screening and implementing them in various European healthcare systems.

[Read more]

SOLACE

The European SOLACE project is investigating how to improve access to early lung cancer screening and, in particular, how to better reach hard-to-reach and underserved populations.

[Read more]

Selected Publications

2025 - Int J Epidemiol. 2025 Jun 11;54(4)
2025 - JAMA Netw Open. 2025 Jul 1;8(7)
2025 - Br J Cancer. 2025 Jun;132(12):1158-1166.
2025 - Clin Cancer Res. 2025 Jun 13;31(12):2441-2453.
All Publications

Get in touch with us

Employee image

Heike Weis

Sekretariat

Postal address:

Krebsepidemiologie (C180) Deutsches Krebsforschungszentrum Deutsches Krebsforschungszentrum Im Neuenheimer Feld 581 69120 Heidelberg
Employee image

Petra Rössler

Sekretariat

Postal address:

Krebsepidemiologie (C180) Deutsches Krebsforschungszentrum Deutsches Krebsforschungszentrum Im Neuenheimer Feld 581 69120 Heidelberg
Form

Form data is loaded ...